Please assess the completion status of the following clinical trial:

Trial Title: Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed of primary or mixed dementia (CIE 10criteria)~* Weihgt loss \>5% of habitual weight in the last 6 months and proteic-caloric malnutrition (MNA \<17)~* Outpatients~* Patients that accept the participation in the study~Exclusion Criteria:~* Vascular pure Dementia and secondary dementias( vascular dementia, Parkinson disease,etc)~* Dementia in a terminal phase: category of FAST 7c in the Reisber scale~* Concomitant treatment with steroids, androgens or other drugs with progestagens~* Weight loss secondary to neoplasia

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Megestrol acetate 160 mg b.i.d. during 24 weeks
- 2 (Type: PLACEBO_COMPARATOR): 1 sachet of powder of placebo b.i.d. during 24 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).